A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The main objectives are: ‐ Part I: To investigate safety, tolerability, and pharmacokinetics (PK) of BI 706321 in healthy male subjects following oral administration of single rising doses. ‐ Part II: The relative bioavailability of BI 706321 after administration of tablets and capsules under fasted conditions will be compared with each other and the effect of food on the tablet bioavailability will be investigated.
Epistemonikos ID: 2d3faf15bc11b83dcea8148d163f95abb7977526
First added on: Oct 03, 2023